CARDIOVASCULAR MEDICINE

Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey

K Miura¹, H Nakagawa¹, Y Morikawa¹, S Sasayama², A Matsumori², K Hasegawa², Y Ohno³, A Tamakoshi³, T Kawamura⁴, Y Inaba⁵

¹ Department of Public Health, Kanazawa Medical University, Ishikawa, Japan
² Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
³ Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁴ Kyoto University Centre for Student Health, Kyoto, Japan
⁵ Department of Epidemiology, Juntendo University School of Medicine, Tokyo, Japan

Correspondence to:
Correspondence to:
Dr K Miura, Department of Public Health, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan;
miura{at}kanazawa-med.ac.jp

Objective: To estimate the total number of patients with idiopathic cardiomyopathy in Japan and the prevalence of the disorder.

Design: A nationwide epidemiological survey.

Setting: Hospitals selected randomly from among all hospitals in Japan.

Patients: Patients presenting with any of the three types of idiopathic cardiomyopathy: dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy.

Main outcome measures: The total number of patients in Japan was estimated using the sampling and response rates in each stratum with respect to hospital size. The second survey was conducted for patients reported in the first survey in order to obtain detailed information, including age, sex, and specific clinical data.

Results: Estimated patient totals and 95% confidence intervals (CI) were 17 700 (95% CI 16 500 to 18 800) for dilated cardiomyopathy, 21 900 (95% CI 20 600 to 23 200) for hypertrophic cardiomyopathy, and 300 (95% CI 250 to 350) for restrictive cardiomyopathy. Crude prevalence per 100 000 population was estimated as 14.0 for dilated cardiomyopathy, 17.3 for hypertrophic cardiomyopathy, and 0.2 for restrictive cardiomyopathy; crude incidence per 100 000 person-years was estimated as 3.58, 4.14, and 0.06, respectively.

Conclusions: The total number and prevalence of patients with idiopathic cardiomyopathy in Japan are estimated for the first time in a nationwide survey. The prevalence of dilated cardiomyopathy in Japan appears to be about half that of Western populations, while that of hypertrophic cardiomyopathy is about the same.

Keywords: cardiomyopathy; epidemiology; Japan

Abbreviations: ISFC, International Society and Federation of Cardiology; WHO, World Health Organization

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Osoegawa, M, Kira, J, Fukazawa, T, Fujihara, K, Kikuchi, S, Matsui, M, Kohriyama, T, Sobue, G, Yamamura, T, Itoyama, Y, Saida, T, Sakata, K, Ochi, H, Matsuoka, T, and The Research Committee of Neuroimmunological D, (2009). Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 15: 159-173 [Abstract]  
• Andrews, R. E., Fenton, M. J., Ridout, D. A., Burch, M., on Behalf of the British Congenital Cardiac Associ, (2008). New-Onset Heart Failure Due to Heart Muscle Disease in Childhood: A Prospective Study in the United Kingdom and Ireland. Circulation 117: 79-84 [Abstract] [Full Text]  
• Nasermoaddeli, A., Miura, K., Matsumori, A., Soyama, Y., Morikawa, Y., Kitabatake, A., Inaba, Y., Nakagawa, H. (2007). Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart 93: 711-715 [Abstract] [Full Text]  
• Corrado, D., Pelliccia, A., Bjornstad, H. H., Vanhees, L., Biffi, A., Borjesson, M., Panhuyzen-Goedkoop, N., Deligiannis, A., Solberg, E., Dugmore, D., Mellwig, K. P., Assanelli, D., Delise, P., van-Buuren, F., Anastasakis, A., Heidbuchel, H., Hoffmann, E., Fagard, R., Priori, S. G., Basso, C., Arbustini, E., Blomstrom-Lundqvist, C., McKenna, W. J., Thiene, G. (2005). Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26: 516-524 [Abstract] [Full Text]